Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;5(6 Suppl):4-16.

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes

Affiliations

Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes

Stephen B Hanauer et al. Gastroenterol Hepatol (N Y). 2009 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of Conflicts of Interest:Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relation-ships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Stephen B. Hanauer, MD: Dr. Hanauer discloses the following. Consulting fees: Axcan Pharma, Procter & Gamble Pharmaceuticals, Shire Pharmaceuticals, Salix Pharmaceuticals, Dr. Falk Pharma.

Daniel H. Present, MD: Dr. Present discloses the following. Grant/Research support: Abbott Laboratories, Alaven, Centocor, Inc., Crohn’s and Colitis Foundation of America, Elan Pharmaceuticals, Inc., Mayo Clinic, Procter & Gamble Pharmaceuticals, National Institutes of Health (University of Pennsylvania), Tech Lab, Teva Pharmaceuticals, USA, UCB, Inc. Consultant/Scientific advisor: Abbott Laboratories, Alaven, Axcan Pharma, Centocor, Inc., Elan Pharmaceuticals, Procter & Gamble Pharmaceuticals, Salix Pharmaceuticals, UCB, Inc. Speaker’s bureau: Axcan Pharma, Elan Pharmaceuticals, Procter & Gamble Pharmaceuticals, Salix Pharmaceuticals, Shire Pharmaceuticals, UCB, Inc.

David T. Rubin, MD: Dr. Rubin discloses the following. Consulting fees: Shire Pharmaceuticals, Salix Pharmaceuticals, Procter & Gamble Pharmaceuticals, Axcan Pharma, Centocor, Inc. Grant support: Salix Pharmaceuticals, Procter & Gamble Pharmaceuticals.

The following planners and managers, Linda Graham, RN, BSN, BA, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Figures

Figure 1
Figure 1
Etiology and pathogenesis of ulcerative colitis.
Figure 2
Figure 2
The ulcerative colitis continuum: endoscopic extent of disease.
Figure 3
Figure 3
Topical action of 5-ASA: extent of disease impacts formulation choice.
Figure 4
Figure 4
5-ASA suppositories: higher remission rates vs oral 5-ASA in ulcerative proctitis.
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/
None
For a free electronic download of these slides, please direct your browser to the following web address: http://www.clinicaladvances.com/index.php/our_publications/gastro_hep-issue/gh_June_2009/

References

    1. Loftus EV, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmstead county, Minnesota, 1940-1993: Incidence, prevalence and survival. Gut. 2000;46:336–343. - PMC - PubMed
    1. Kornbluth A, Sachar B. Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371–1385. - PubMed
    1. Farmer RG, Easley KA, Rankin GB. Dig Dis Sci. 1993;38:1137–1146. - PubMed
    1. Safdi M, DeMicco M, Sninsky C, et al. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis. Am J Gastroenterol. 1997;92:1867–1871. - PubMed
    1. Lichtenstein GR, Kamm MA, Sandborn WJ, et al. MMX mesalazine for the induction of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Aliment Pharmacol Ther. 2008;1:1094–1102. - PubMed

LinkOut - more resources